Tirzepatide

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 2454 publications

Corrigendum to "Impact of tirzepatide on systemic arterial stiffness assessed by cardio-ankle vascular index in individuals with obesity complicated by type 2 diabetes: A retrospective cohort study in Japan" [Obesity Pillars 19 (2026) 100291].

Corrigendum to "Impact of tirzepatide on systemic arterial stiffness assessed by cardio-ankle vascular index in individuals with obesity complicated by type 2 diabetes: A retrospective cohort study in Japan" [Obesity Pillars 19 (2026) 100291].

Journal: Obesity pillars

Published: September 04, 2026

Adjunctive Treatments for Patients with Type 1 Diabetes Using Automated Insulin Delivery Systems. A Narrative Review.

Adjunctive Treatments for Patients with Type 1 Diabetes Using Automated Insulin Delivery Systems. A Narrative Review.

Journal: Diabetes technology & therapeutics

Published: September 04, 2026

Recent Advances in Glucagon-Like Peptide-1 Receptor and Melanocortin-4 Receptor Agonists for the Treatment of Obesity and Type 2 Diabetes.

Recent Advances in Glucagon-Like Peptide-1 Receptor and Melanocortin-4 Receptor Agonists for the Treatment of Obesity and Type 2 Diabetes.

Journal: Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme

Published: September 04, 2026

Glucagon-Like Peptide-1 Receptor Agonists for Obstructive Sleep Apnea: A Review.

Glucagon-Like Peptide-1 Receptor Agonists for Obstructive Sleep Apnea: A Review.

Journal: JAMA otolaryngology-- head & neck surgery

Published: September 03, 2026

From insulin resistance to incretin receptor agonism in the prevention of type 2 diabetes mellitus in obese individuals.

From insulin resistance to incretin receptor agonism in the prevention of type 2 diabetes mellitus in obese individuals.

Journal: Current medical research and opinion

Published: September 03, 2026

Integrating the liver into the cardiovascular-kidney-metabolic syndrome: pathophysiology and therapeutic implications.

Integrating the liver into the cardiovascular-kidney-metabolic syndrome: pathophysiology and therapeutic implications.

Journal: Current opinion in nephrology and hypertension

Published: September 02, 2026

Efficacy and Safety of Glucagon-like Peptide-1 Receptor Agonists and Co-agonists for Weight Loss Among Adults Without Diabetes : An Updated Systematic Review.

Efficacy and Safety of Glucagon-like Peptide-1 Receptor Agonists and Co-agonists for Weight Loss Among Adults Without Diabetes : An Updated Systematic Review.

Journal: Annals of internal medicine

Published: August 31, 2026

In adults with early uncontrolled T2D, tirzepatide vs. intensified conventional care reduced HbA1c levels and weight at 2 y.

In adults with early uncontrolled T2D, tirzepatide vs. intensified conventional care reduced HbA1c levels and weight at 2 y.

Journal: Annals of internal medicine

Published: August 31, 2026

Glucagon-Like Peptide 1 Receptor Agonists, Mortality, and Cardiovascular Outcomes in Serious Mental Illness.

Glucagon-Like Peptide 1 Receptor Agonists, Mortality, and Cardiovascular Outcomes in Serious Mental Illness.

Journal: JAMA psychiatry

Published: August 26, 2026

Clinical practice patterns and unmet needs in the use of GLP-1 receptor agonists in sleep medicine: A pan-European survey performed in the European sleep apnoea database network.

Clinical practice patterns and unmet needs in the use of GLP-1 receptor agonists in sleep medicine: A pan-European survey performed in the European sleep apnoea database network.

Journal: Pulmonology

Published: August 25, 2026

A multi-functional oral small molecule targeting energy and lipid metabolism to treat obesity and related metabolic disorders.

A multi-functional oral small molecule targeting energy and lipid metabolism to treat obesity and related metabolic disorders.

Journal: Science advances

Published: August 21, 2026

Highlights from JAAD Reviews: Skin in the Game: Dermatologic and Medicolegal Aspects of Glucagon-Like Peptide-1 Receptor Agonists.

Highlights from JAAD Reviews: Skin in the Game: Dermatologic and Medicolegal Aspects of Glucagon-Like Peptide-1 Receptor Agonists.

Journal: Journal of the American Academy of Dermatology

Published: August 20, 2026

Showing 1-12 of 2,454

Last Updated: 09/26/2026